{"id":399,"date":"2026-04-14T12:06:04","date_gmt":"2026-04-14T12:06:04","guid":{"rendered":"https:\/\/nutra-supplements.com\/?p=399"},"modified":"2026-04-14T12:29:32","modified_gmt":"2026-04-14T12:29:32","slug":"preservision-areds2-review","status":"publish","type":"post","link":"https:\/\/nutra-supplements.com\/fr\/preservision-areds2-review\/","title":{"rendered":"PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard? | Nutra Supplements"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"399\" class=\"elementor elementor-399\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1161a20 e-flex e-con-boxed e-con e-parent\" data-id=\"1161a20\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-50fad5e elementor-widget elementor-widget-html\" data-id=\"50fad5e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<!DOCTYPE html>\r\n<html lang=\"en\">\r\n<head>\r\n<meta charset=\"UTF-8\">\r\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\r\n\r\n<title>PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard? | Nutra Supplements<\/title>\r\n<meta name=\"description\" content=\"An in-depth, independent review of PreserVision AREDS2 in 2026. We examine its ingredient quality, clinical evidence, what it does well, where it falls short, and whether newer formulas have surpassed it.\">\r\n<meta name=\"keywords\" content=\"PreserVision AREDS2 review, PreserVision AREDS2 2026, is PreserVision AREDS2 the best, PreserVision AREDS2 ingredients, AREDS2 supplement review, best AMD supplement 2026\">\r\n<meta name=\"robots\" content=\"index, follow\">\r\n<link rel=\"canonical\" href=\"https:\/\/nutra-supplements.com\/preservision-areds2-review\/\">\r\n\r\n<meta property=\"og:type\" content=\"article\">\r\n<meta property=\"og:title\" content=\"PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard?\">\r\n<meta property=\"og:description\" content=\"In-depth independent review of PreserVision AREDS2 \u2014 clinical evidence, ingredients, pros, cons and how it compares to newer premium formulas.\">\r\n<meta property=\"og:url\" content=\"https:\/\/nutra-supplements.com\/preservision-areds2-review\/\">\r\n<meta property=\"og:site_name\" content=\"Nutra Supplements\">\r\n<meta property=\"article:published_time\" content=\"2026-04-13T00:00:00Z\">\r\n<meta property=\"article:section\" content=\"Vision Health\">\r\n\r\n<meta name=\"twitter:card\" content=\"summary_large_image\">\r\n<meta name=\"twitter:title\" content=\"PreserVision AREDS2 Review 2026 \u2014 Is It Still the Gold Standard?\">\r\n<meta name=\"twitter:description\" content=\"Independent review: ingredients, clinical evidence, what it does well and where newer formulas have surpassed it.\">\r\n\r\n<script type=\"application\/ld+json\">\r\n{\r\n  \"@context\": \"https:\/\/schema.org\",\r\n  \"@type\": \"Review\",\r\n  \"name\": \"PreserVision AREDS2 Review (2026)\",\r\n  \"headline\": \"PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard?\",\r\n  \"description\": \"An independent, in-depth review of PreserVision AREDS2 examining ingredient quality, clinical evidence, and how it compares to newer premium eye formulas.\",\r\n  \"author\": { \"@type\": \"Organization\", \"name\": \"Nutra Supplements\", \"url\": \"https:\/\/nutra-supplements.com\" },\r\n  \"publisher\": { \"@type\": \"Organization\", \"name\": \"Nutra Supplements\", \"url\": \"https:\/\/nutra-supplements.com\" },\r\n  \"datePublished\": \"2026-04-13\",\r\n  \"dateModified\": \"2026-04-13\",\r\n  \"itemReviewed\": {\r\n    \"@type\": \"Product\",\r\n    \"name\": \"PreserVision AREDS2\",\r\n    \"brand\": { \"@type\": \"Brand\", \"name\": \"Bausch + Lomb\" },\r\n    \"category\": \"Eye Health Supplement\",\r\n    \"aggregateRating\": {\r\n      \"@type\": \"AggregateRating\",\r\n      \"ratingValue\": \"4.2\",\r\n      \"reviewCount\": \"1\",\r\n      \"bestRating\": \"5\",\r\n      \"worstRating\": \"1\"\r\n    }\r\n  },\r\n  \"reviewRating\": {\r\n    \"@type\": \"Rating\",\r\n    \"ratingValue\": \"4.2\",\r\n    \"bestRating\": \"5\",\r\n    \"worstRating\": \"1\"\r\n  },\r\n  \"mainEntityOfPage\": { \"@type\": \"WebPage\", \"@id\": \"https:\/\/nutra-supplements.com\/preservision-areds2-review\/\" }\r\n}\r\n<\/script>\r\n\r\n\r\n<script type=\"application\/ld+json\">\r\n{\r\n  \"@context\": \"https:\/\/schema.org\",\r\n  \"@type\": \"FAQPage\",\r\n  \"mainEntity\": [\r\n    {\r\n      \"@type\": \"Question\",\r\n      \"name\": \"Is PreserVision AREDS2 worth taking?\",\r\n      \"acceptedAnswer\": {\r\n        \"@type\": \"Answer\",\r\n        \"text\": \"Yes \u2014 for its intended population. PreserVision AREDS2 is the only supplement formula tested in a large-scale, multi-year randomised controlled trial (n=4,203) for AMD progression. For people with intermediate AMD or advanced AMD in one eye, it is the most evidence-backed option available. For general eye health prevention in people without AMD, it is a solid foundation but lacks astaxanthin, meso-zeaxanthin and higher omega-3 doses that premium formulas now include.\"\r\n      }\r\n    },\r\n    {\r\n      \"@type\": \"Question\",\r\n      \"name\": \"What are the side effects of PreserVision AREDS2?\",\r\n      \"acceptedAnswer\": {\r\n        \"@type\": \"Answer\",\r\n        \"text\": \"The most common concern is the 80 mg zinc dose, which can deplete copper over time \u2014 the formula includes 2 mg copper to address this. Some users experience mild gastrointestinal discomfort from the high zinc dose. Vitamin C at 500 mg may cause stomach upset in sensitive individuals when taken without food. The formula does not contain preformed vitamin A (retinol), so there is no toxicity risk from that source. Always take with a meal.\"\r\n      }\r\n    },\r\n    {\r\n      \"@type\": \"Question\",\r\n      \"name\": \"How long does PreserVision AREDS2 take to work?\",\r\n      \"acceptedAnswer\": {\r\n        \"@type\": \"Answer\",\r\n        \"text\": \"In the AREDS2 trial, the primary outcome was progression to advanced AMD over a 5-year period. Measurable increases in macular pigment optical density from the lutein and zeaxanthin component begin appearing after 3\u20136 months of consistent use. Subjective visual improvements are uncommon \u2014 this formula is designed to slow disease progression, not reverse it or improve vision that has already deteriorated.\"\r\n      }\r\n    },\r\n    {\r\n      \"@type\": \"Question\",\r\n      \"name\": \"Can I take PreserVision AREDS2 if I don't have AMD?\",\r\n      \"acceptedAnswer\": {\r\n        \"@type\": \"Answer\",\r\n        \"text\": \"Yes. While AREDS2 was tested in people with existing AMD, the core nutrients \u2014 lutein, zeaxanthin, antioxidant vitamins and zinc \u2014 support macular health at any stage. The 80 mg zinc dose is designed for high-risk AMD patients and may be more than necessary for general prevention; lower-zinc variants (PreserVision AREDS2 with 25 mg zinc) are available and may be more appropriate for healthy adults without AMD.\"\r\n      }\r\n    }\r\n  ]\r\n}\r\n<\/script>\r\n\r\n<link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\r\n<link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\r\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Cormorant+Garamond:ital,wght@0,300;0,400;0,500;0,600;1,300;1,400;1,500&family=DM+Sans:wght@300;400;500&display=swap\" rel=\"stylesheet\">\r\n\r\n<style>\r\n:root {\r\n  --cream:      #FAF7F2;\r\n  --cream-mid:  #F2EDE3;\r\n  --cream-dark: #E8DFD0;\r\n  --bark:       #8B6F47;\r\n  --bark-light: #BFA27A;\r\n  --bark-dark:  #5C4527;\r\n  --ink:        #1E1A14;\r\n  --ink-mid:    #4A4035;\r\n  --ink-light:  #7A6E62;\r\n  --sage:       #7D9E8A;\r\n  --sage-light: #C5D9CC;\r\n  --gold:       #C8973A;\r\n  --gold-light: #E8C87A;\r\n  --white:      #FFFFFF;\r\n  --font-display: 'Cormorant Garamond', Georgia, serif;\r\n  --font-body:    'DM Sans', system-ui, sans-serif;\r\n  --radius-sm: 4px; --radius-md: 8px; --radius-lg: 14px;\r\n  --content-w: 760px; --max-w: 1120px;\r\n}\r\n*, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }\r\nhtml { scroll-behavior: smooth; }\r\nbody { font-family: var(--font-body); background: var(--cream); color: var(--ink); line-height: 1.82; font-size: 17px; font-weight: 300; }\r\nimg { max-width: 100%; display: block; }\r\na { color: var(--bark); text-decoration: none; transition: color 0.2s; }\r\na:hover { color: var(--bark-dark); }\r\nh1,h2,h3,h4 { font-family: var(--font-display); line-height: 1.2; color: var(--ink); }\r\nh1 { font-size: clamp(2rem, 4vw, 3.3rem); font-weight: 400; letter-spacing: -0.02em; }\r\nh2 { font-size: clamp(1.5rem, 2.5vw, 2rem); font-weight: 400; margin: 3rem 0 1rem; }\r\nh3 { font-size: clamp(1.1rem, 1.8vw, 1.4rem); font-weight: 400; margin: 2rem 0 0.7rem; }\r\nh4 { font-size: 1.05rem; font-weight: 500; margin: 1.4rem 0 0.5rem; }\r\np { margin-bottom: 1.35rem; }\r\nstrong { font-weight: 500; color: var(--ink); }\r\n\r\n.container { max-width: var(--max-w); margin: 0 auto; padding: 0 1.5rem; }\r\n.content-wrap { max-width: var(--content-w); margin: 0 auto; }\r\n.progress-bar { background: var(--gold); height: 3px; position: fixed; top: 0; left: 0; z-index: 200; transition: width 0.1s; }\r\n\r\n\/* HEADER *\/\r\nheader.site-header { background: var(--cream); border-bottom: 1px solid var(--cream-dark); padding: 0.9rem 0; position: sticky; top: 3px; z-index: 100; }\r\n.header-inner { display: flex; align-items: center; justify-content: space-between; gap: 1.5rem; }\r\n.logo img { height: 46px; width: auto; }\r\n.nav-links { display: flex; gap: 1.8rem; list-style: none; }\r\n.nav-links a { font-size: 0.78rem; letter-spacing: 0.08em; text-transform: uppercase; color: var(--ink-mid); font-weight: 400; }\r\n.nav-links a:hover { color: var(--bark-dark); }\r\n.lang-switcher { display: flex; align-items: center; gap: 0.15rem; background: var(--cream-mid); border: 1px solid var(--cream-dark); border-radius: 6px; padding: 0.2rem; }\r\n.lang-btn { background: none; border: none; color: var(--ink-light); font-family: var(--font-body); font-size: 0.7rem; font-weight: 500; letter-spacing: 0.06em; text-transform: uppercase; cursor: pointer; padding: 0.32rem 0.6rem; border-radius: 4px; transition: color 0.18s, background 0.18s; }\r\n.lang-btn:hover { color: var(--bark-dark); background: var(--cream-dark); }\r\n.lang-btn.active { background: var(--ink); color: var(--cream); }\r\n\r\n\/* BREADCRUMB *\/\r\n.breadcrumb { padding: 0.9rem 0; background: var(--cream-mid); border-bottom: 1px solid var(--cream-dark); }\r\n.bc-list { display: flex; align-items: center; gap: 0.5rem; list-style: none; font-size: 0.78rem; color: var(--ink-light); flex-wrap: wrap; }\r\n.bc-list li::after { content: '\u203a'; margin-left: 0.5rem; }\r\n.bc-list li:last-child::after { display: none; }\r\n.bc-list a { color: var(--bark); }\r\n\r\n\/* ARTICLE HEADER *\/\r\n.art-header { padding: 3.5rem 0 2.5rem; border-bottom: 1px solid var(--cream-dark); text-align: center; }\r\n.art-tag { display: inline-flex; align-items: center; gap: 0.7rem; font-size: 0.7rem; letter-spacing: 0.2em; text-transform: uppercase; color: var(--gold); font-family: var(--font-body); font-weight: 400; margin-bottom: 1rem; }\r\n.art-tag::before, .art-tag::after { content: ''; display: block; width: 22px; height: 1px; background: var(--gold); }\r\n.art-header h1 { font-style: italic; margin-bottom: 1rem; max-width: 820px; margin-left: auto; margin-right: auto; }\r\n.art-meta { display: flex; align-items: center; justify-content: center; gap: 1.4rem; flex-wrap: wrap; font-size: 0.78rem; color: var(--ink-light); margin-top: 1.2rem; }\r\n.art-meta span { display: flex; align-items: center; gap: 0.35rem; }\r\n.meta-dot { width: 3px; height: 3px; border-radius: 50%; background: var(--cream-dark); }\r\n\r\n.art-body { padding: 3rem 0 4rem; }\r\n\r\n\/* DISCLOSURE *\/\r\n.disclosure { background: var(--cream-mid); border: 1px solid var(--cream-dark); border-radius: var(--radius-md); padding: 1rem 1.3rem; margin-bottom: 2rem; font-size: 0.78rem; color: var(--ink-light); display: flex; gap: 0.7rem; align-items: flex-start; line-height: 1.65; }\r\n.disclosure svg { width: 16px; height: 16px; color: var(--gold); flex-shrink: 0; margin-top: 1px; }\r\n\r\n\/* TOP CTA BAR *\/\r\n.top-cta-bar { background: var(--ink); border-radius: var(--radius-lg); padding: 1.5rem 2rem; display: flex; align-items: center; justify-content: space-between; gap: 1.5rem; margin-bottom: 2.5rem; flex-wrap: wrap; }\r\n.top-cta-bar p { margin: 0; color: var(--bark-light); font-size: 0.88rem; }\r\n.top-cta-bar strong { display: block; color: var(--cream); font-size: 1rem; margin-bottom: 0.2rem; font-family: var(--font-display); font-weight: 400; }\r\n.btn-check { display: inline-flex; align-items: center; gap: 0.5rem; background: var(--gold); color: var(--ink); padding: 0.85rem 1.8rem; border-radius: var(--radius-sm); font-size: 0.76rem; letter-spacing: 0.12em; text-transform: uppercase; font-weight: 500; white-space: nowrap; transition: background 0.2s, transform 0.2s; flex-shrink: 0; }\r\n.btn-check:hover { background: var(--gold-light); color: var(--ink); transform: translateY(-1px); }\r\n.btn-check svg { width: 14px; height: 14px; }\r\n\r\n\/* LEAD *\/\r\n.art-lead { font-size: 1.1rem; color: var(--ink-mid); border-left: 3px solid var(--sage); padding-left: 1.4rem; margin-bottom: 2rem; font-style: italic; line-height: 1.85; font-family: var(--font-display); }\r\n\r\n\/* TOC *\/\r\n.toc { background: var(--white); border: 1px solid var(--cream-dark); border-left: 3px solid var(--gold); border-radius: var(--radius-lg); padding: 1.6rem 1.8rem; margin-bottom: 2.8rem; }\r\n.toc-title { font-family: var(--font-display); font-size: 1.05rem; font-weight: 500; color: var(--ink); margin-bottom: 0.9rem; display: flex; align-items: center; gap: 0.6rem; }\r\n.toc-list { list-style: none; counter-reset: toc; }\r\n.toc-list li { counter-increment: toc; margin-bottom: 0.4rem; }\r\n.toc-list li a { font-size: 0.88rem; color: var(--ink-mid); display: flex; align-items: baseline; gap: 0.55rem; }\r\n.toc-list li a::before { content: counter(toc, decimal-leading-zero); font-family: var(--font-display); font-size: 0.82rem; color: var(--gold); font-weight: 400; flex-shrink: 0; }\r\n.toc-list li a:hover { color: var(--bark-dark); }\r\n\r\n\/* VERDICT CARD *\/\r\n.verdict-card { background: var(--white); border: 1px solid var(--cream-dark); border-radius: var(--radius-lg); padding: 2rem; margin: 2rem 0; }\r\n.verdict-header { display: flex; align-items: flex-start; justify-content: space-between; gap: 1.5rem; margin-bottom: 1.5rem; flex-wrap: wrap; }\r\n.verdict-title { font-family: var(--font-display); font-size: 1.4rem; font-weight: 400; color: var(--ink); margin-bottom: 0.3rem; }\r\n.verdict-sub { font-size: 0.82rem; color: var(--ink-light); font-style: italic; }\r\n.overall-score { text-align: center; flex-shrink: 0; }\r\n.overall-score .score-num { font-family: var(--font-display); font-size: 3.5rem; font-weight: 300; color: var(--gold); line-height: 1; }\r\n.overall-score .score-max { font-size: 1.2rem; color: var(--ink-light); }\r\n.overall-score .score-label-text { font-size: 0.7rem; letter-spacing: 0.1em; text-transform: uppercase; color: var(--ink-light); display: block; margin-top: 0.2rem; }\r\n.score-bars { display: grid; grid-template-columns: 1fr 1fr; gap: 0.8rem; margin-top: 1.2rem; }\r\n.score-bar-item { }\r\n.bar-label { display: flex; justify-content: space-between; font-size: 0.75rem; color: var(--ink-mid); margin-bottom: 0.3rem; }\r\n.bar-label span { font-weight: 500; color: var(--bark); }\r\n.bar-track { height: 6px; background: var(--cream-dark); border-radius: 3px; overflow: hidden; }\r\n.bar-fill { height: 100%; background: var(--gold); border-radius: 3px; }\r\n\r\n\/* PRODUCT SNAPSHOT *\/\r\n.product-snapshot { display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; margin: 1.5rem 0; }\r\n.snapshot-item { background: var(--cream-mid); border-radius: var(--radius-md); padding: 0.9rem 1.1rem; }\r\n.snapshot-item .s-label { font-size: 0.65rem; letter-spacing: 0.12em; text-transform: uppercase; color: var(--ink-light); margin-bottom: 0.25rem; display: block; }\r\n.snapshot-item .s-value { font-size: 0.92rem; color: var(--ink); font-weight: 400; }\r\n\r\n\/* CALLOUT *\/\r\n.callout { background: var(--white); border: 1px solid var(--cream-dark); border-radius: var(--radius-lg); padding: 1.4rem 1.7rem; margin: 2rem 0; display: flex; gap: 1.1rem; align-items: flex-start; }\r\n.callout-gold { border-left: 4px solid var(--gold); }\r\n.callout-sage { border-left: 4px solid var(--sage); }\r\n.callout-warn { border-left: 4px solid var(--bark-light); }\r\n.callout-icon { width: 36px; height: 36px; flex-shrink: 0; border-radius: 50%; display: flex; align-items: center; justify-content: center; }\r\n.callout-gold .callout-icon { background: rgba(200,151,58,0.1); }\r\n.callout-sage .callout-icon { background: rgba(125,158,138,0.1); }\r\n.callout-warn .callout-icon { background: rgba(139,111,71,0.1); }\r\n.callout-icon svg { width: 18px; height: 18px; }\r\n.callout-gold .callout-icon svg { color: var(--gold); }\r\n.callout-sage .callout-icon svg { color: var(--sage); }\r\n.callout-warn .callout-icon svg { color: var(--bark); }\r\n.callout-body p { font-size: 0.9rem; margin-bottom: 0; color: var(--ink-mid); line-height: 1.75; }\r\n.callout-body strong { display: block; margin-bottom: 0.3rem; font-size: 0.93rem; color: var(--ink); }\r\n\r\n\/* INGREDIENTS TABLE *\/\r\n.ing-table { width: 100%; border-collapse: collapse; font-size: 0.86rem; margin: 1.2rem 0; }\r\n.ing-table thead { background: var(--ink); }\r\n.ing-table th { padding: 0.7rem 1rem; text-align: left; font-size: 0.68rem; letter-spacing: 0.1em; text-transform: uppercase; color: var(--cream); font-weight: 400; }\r\n.ing-table td { padding: 0.7rem 1rem; border-bottom: 1px solid var(--cream-mid); color: var(--ink-mid); }\r\n.ing-table td:first-child { font-weight: 500; color: var(--ink); }\r\n.ing-table tr:last-child td { border-bottom: none; }\r\n.ing-table tr:nth-child(even) { background: var(--cream-mid); }\r\n.dose-ok  { color: #2e7d5e; font-weight: 500; }\r\n.dose-low { color: #c0392b; font-weight: 500; }\r\n.dose-mid { color: var(--gold); font-weight: 500; }\r\n\r\n\/* PROS CONS *\/\r\n.pros-cons { display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; margin: 1.8rem 0; }\r\n.pros, .cons { background: var(--cream-mid); border-radius: var(--radius-md); padding: 1.2rem 1.4rem; }\r\n.pros { border-left: 3px solid var(--sage); }\r\n.cons { border-left: 3px solid var(--bark-light); }\r\n.pros h4, .cons h4 { font-size: 0.78rem; letter-spacing: 0.12em; text-transform: uppercase; margin-bottom: 0.8rem; }\r\n.pros h4 { color: #4e7d6a; }\r\n.cons h4 { color: var(--bark); }\r\n.pros ul, .cons ul { list-style: none; padding: 0; }\r\n.pros li, .cons li { font-size: 0.85rem; color: var(--ink-mid); padding: 0.3rem 0 0.3rem 1.4rem; position: relative; border-bottom: 1px solid rgba(0,0,0,0.05); }\r\n.pros li:last-child, .cons li:last-child { border-bottom: none; }\r\n.pros li::before { content: '\u2713'; position: absolute; left: 0; color: var(--sage); font-weight: 500; }\r\n.cons li::before { content: '\u2212'; position: absolute; left: 0; color: var(--bark-light); font-weight: 500; }\r\n\r\n\/* WHO IS IT FOR *\/\r\n.who-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; margin: 1.5rem 0; }\r\n.who-card { background: var(--white); border: 1px solid var(--cream-dark); border-radius: var(--radius-md); padding: 1.2rem; }\r\n.who-card .w-icon { font-size: 0.68rem; letter-spacing: 0.12em; text-transform: uppercase; margin-bottom: 0.6rem; display: block; }\r\n.who-yes { color: #4e7d6a; }\r\n.who-no  { color: var(--bark); }\r\n.who-card h4 { font-size: 0.95rem; margin: 0 0 0.5rem; }\r\n.who-card p { font-size: 0.82rem; color: var(--ink-light); margin: 0; line-height: 1.6; }\r\n\r\n\/* COMPARISON VS *\/\r\n.vs-table-wrap { overflow-x: auto; margin: 2rem 0; border-radius: var(--radius-lg); border: 1px solid var(--cream-dark); }\r\n.vs-table { width: 100%; border-collapse: collapse; font-size: 0.85rem; min-width: 540px; }\r\n.vs-table thead { background: var(--ink); }\r\n.vs-table th { padding: 0.8rem 1rem; text-align: left; font-size: 0.68rem; letter-spacing: 0.1em; text-transform: uppercase; color: var(--cream); font-weight: 400; }\r\n.vs-table td { padding: 0.8rem 1rem; border-bottom: 1px solid var(--cream-dark); color: var(--ink-mid); vertical-align: middle; }\r\n.vs-table tr:last-child td { border-bottom: none; }\r\n.vs-table tr:nth-child(even) { background: var(--cream-mid); }\r\n.vs-table td:first-child { font-weight: 500; color: var(--ink); font-family: var(--font-display); font-size: 0.96rem; }\r\n.vs-table td.highlight { color: var(--gold); font-weight: 500; }\r\n.check { color: #2e7d5e; } .cross { color: #c0392b; } .partial { color: var(--gold); }\r\n\r\n\/* SECTION DIVIDER *\/\r\n.sec-divider { display: flex; align-items: center; gap: 1rem; margin: 3rem 0 2rem; }\r\n.sec-divider span { font-size: 0.68rem; letter-spacing: 0.2em; text-transform: uppercase; color: var(--gold); font-family: var(--font-body); white-space: nowrap; }\r\n.sec-divider::before, .sec-divider::after { content: ''; flex: 1; height: 1px; background: var(--cream-dark); }\r\n\r\n\/* CTA BOXES *\/\r\n.mid-cta { background: var(--cream-mid); border: 1px solid var(--cream-dark); border-radius: var(--radius-lg); padding: 1.8rem 2rem; margin: 2.5rem 0; display: flex; align-items: center; justify-content: space-between; gap: 1.5rem; flex-wrap: wrap; }\r\n.mid-cta-text strong { display: block; font-family: var(--font-display); font-size: 1.2rem; color: var(--ink); margin-bottom: 0.25rem; }\r\n.mid-cta-text p { font-size: 0.86rem; color: var(--ink-light); margin: 0; }\r\n.btn-mid { display: inline-flex; align-items: center; gap: 0.5rem; background: var(--ink); color: var(--cream); padding: 0.82rem 1.7rem; border-radius: var(--radius-sm); font-size: 0.75rem; letter-spacing: 0.11em; text-transform: uppercase; font-weight: 500; white-space: nowrap; transition: background 0.2s; }\r\n.btn-mid:hover { background: var(--bark-dark); color: var(--cream); }\r\n\r\n.final-cta { background: var(--ink); border-radius: var(--radius-lg); padding: 2.5rem 2rem; margin: 3rem 0; text-align: center; position: relative; overflow: hidden; }\r\n.final-cta::before { content: ''; position: absolute; top: -50%; left: 50%; transform: translateX(-50%); width: 400px; height: 400px; background: radial-gradient(circle, rgba(200,151,58,0.07) 0%, transparent 70%); pointer-events: none; }\r\n.final-cta h2 { color: var(--cream); font-style: italic; margin-top: 0; margin-bottom: 0.7rem; font-size: 1.7rem; position: relative; z-index: 1; }\r\n.final-cta p { color: var(--bark-light); font-size: 0.9rem; max-width: 460px; margin: 0 auto 1.8rem; position: relative; z-index: 1; }\r\n.cta-btn-row { display: flex; gap: 0.8rem; justify-content: center; flex-wrap: wrap; position: relative; z-index: 1; }\r\n.btn-gold { display: inline-flex; align-items: center; gap: 0.5rem; background: var(--gold); color: var(--ink); padding: 0.88rem 2rem; border-radius: var(--radius-sm); font-size: 0.76rem; letter-spacing: 0.12em; text-transform: uppercase; font-weight: 500; transition: background 0.2s, transform 0.2s; }\r\n.btn-gold:hover { background: var(--gold-light); color: var(--ink); transform: translateY(-1px); }\r\n.btn-ghost-light { display: inline-flex; align-items: center; gap: 0.5rem; border: 1px solid rgba(191,162,122,0.4); color: var(--bark-light); padding: 0.88rem 2rem; border-radius: var(--radius-sm); font-size: 0.76rem; letter-spacing: 0.12em; text-transform: uppercase; font-weight: 400; transition: border-color 0.2s, color 0.2s; }\r\n.btn-ghost-light:hover { border-color: var(--bark-light); color: var(--cream); }\r\n\r\n\/* FAQ *\/\r\n.faq-item { border-bottom: 1px solid var(--cream-dark); padding: 1.1rem 0; }\r\n.faq-item:last-child { border-bottom: none; }\r\n.faq-q { font-family: var(--font-display); font-size: 1.08rem; font-weight: 500; color: var(--ink); cursor: pointer; display: flex; justify-content: space-between; align-items: flex-start; gap: 1rem; user-select: none; }\r\n.faq-q svg { width: 18px; height: 18px; color: var(--gold); flex-shrink: 0; margin-top: 3px; transition: transform 0.3s; }\r\n.faq-q.open svg { transform: rotate(45deg); }\r\n.faq-a { font-size: 0.91rem; color: var(--ink-light); line-height: 1.8; display: none; padding-top: 0.8rem; }\r\n.faq-a.visible { display: block; }\r\n\r\n\/* SHARE *\/\r\n.share-bar { display: flex; align-items: center; gap: 0.8rem; flex-wrap: wrap; padding: 1.4rem 0; border-top: 1px solid var(--cream-dark); border-bottom: 1px solid var(--cream-dark); margin: 2.5rem 0; }\r\n.share-label { font-size: 0.72rem; letter-spacing: 0.1em; text-transform: uppercase; color: var(--ink-light); }\r\n.share-btn { display: inline-flex; align-items: center; gap: 0.4rem; border: 1px solid var(--cream-dark); border-radius: 20px; padding: 0.32rem 0.9rem; font-size: 0.74rem; color: var(--ink-mid); background: var(--white); font-family: var(--font-body); cursor: pointer; transition: border-color 0.2s, color 0.2s; }\r\n.share-btn:hover { border-color: var(--bark-light); color: var(--bark-dark); }\r\n\r\n\/* RELATED *\/\r\n.related-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 1.2rem; margin-top: 1.4rem; }\r\n.related-card { background: var(--white); border: 1px solid var(--cream-dark); border-radius: var(--radius-lg); padding: 1.2rem 1.4rem; transition: transform 0.2s, box-shadow 0.2s; }\r\n.related-card:hover { transform: translateY(-3px); box-shadow: 0 8px 24px rgba(92,69,39,0.08); }\r\n.related-type { font-size: 0.64rem; letter-spacing: 0.14em; text-transform: uppercase; color: var(--gold); margin-bottom: 0.35rem; display: block; }\r\n.related-title { font-family: var(--font-display); font-size: 1rem; color: var(--ink); line-height: 1.3; }\r\n\r\n\/* FOOTER *\/\r\nfooter { background: var(--ink); border-top: 1px solid rgba(191,162,122,0.15); padding: 2rem 0; text-align: center; }\r\n.footer-disclaimer { font-size: 0.77rem; color: var(--ink-light); max-width: 700px; margin: 0 auto 1.2rem; line-height: 1.7; }\r\n.footer-links { display: flex; justify-content: center; gap: 1.5rem; flex-wrap: wrap; margin-bottom: 1rem; }\r\n.footer-links a { font-size: 0.77rem; color: var(--bark-light); }\r\n.footer-links a:hover { color: var(--gold-light); }\r\n.footer-copy { font-size: 0.74rem; color: var(--ink-light); }\r\n\r\n@media (max-width: 720px) {\r\n  .score-bars { grid-template-columns: 1fr; }\r\n  .product-snapshot { grid-template-columns: 1fr; }\r\n  .pros-cons { grid-template-columns: 1fr; }\r\n  .who-grid { grid-template-columns: 1fr; }\r\n  .mid-cta { flex-direction: column; text-align: center; }\r\n  .related-grid { grid-template-columns: 1fr; }\r\n  .cta-btn-row { flex-direction: column; align-items: center; }\r\n  .nav-links { display: none; }\r\n  .top-cta-bar { flex-direction: column; text-align: center; }\r\n  .verdict-header { flex-direction: column; }\r\n}\r\n<\/style>\r\n<\/head>\r\n<body>\r\n\r\n<div class=\"progress-bar\" id=\"progress\"><\/div>\r\n\r\n<!-- HEADER -->\r\n<header class=\"site-header\">\r\n  <div class=\"container\">\r\n    <div class=\"header-inner\">\r\n      <a href=\"\/\" class=\"logo\">\r\n        <img decoding=\"async\" src=\"\/images\/logonutrasupplements-180x70.jpg\" alt=\"Nutra Supplements\">\r\n      <\/a>\r\n      <ul class=\"nav-links\">\r\n        <li><a href=\"\/category\/vision-health\/\">Vision Health<\/a><\/li>\r\n        <li><a href=\"\/best-eye-vitamins-complete-formula\/\">Complete Formulas<\/a><\/li>\r\n        <li><a href=\"\/\">Home<\/a><\/li>\r\n      <\/ul>\r\n      <div class=\"lang-switcher\">\r\n        <button class=\"lang-btn active\">EN<\/button>\r\n        <button class=\"lang-btn\">ES<\/button>\r\n        <button class=\"lang-btn\">DE<\/button>\r\n        <button class=\"lang-btn\">FR<\/button>\r\n        <button class=\"lang-btn\">IT<\/button>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/header>\r\n\r\n<!-- BREADCRUMB -->\r\n<nav class=\"breadcrumb\" aria-label=\"Breadcrumb\">\r\n  <div class=\"container\">\r\n    <ol class=\"bc-list\">\r\n      <li><a href=\"\/\">Home<\/a><\/li>\r\n      <li><a href=\"\/category\/vision-health\/\">Vision Health<\/a><\/li>\r\n      <li><a href=\"\/best-eye-vitamins-complete-formula\/\">Complete Eye Formulas<\/a><\/li>\r\n      <li aria-current=\"page\">PreserVision AREDS2 Review<\/li>\r\n    <\/ol>\r\n  <\/div>\r\n<\/nav>\r\n\r\n<!-- ARTICLE HEADER -->\r\n<header class=\"art-header\">\r\n  <div class=\"container\">\r\n    <div class=\"content-wrap\" style=\"max-width:820px;\">\r\n      <div class=\"art-tag\">Product Review \u00b7 Vision Health<\/div>\r\n      <h1>PreserVision AREDS2 Review (2026) \u2014 <em>Is It Still the Gold Standard?<\/em><\/h1>\r\n      <div class=\"art-meta\">\r\n        <span>\r\n          <svg width=\"14\" height=\"14\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><rect x=\"3\" y=\"4\" width=\"18\" height=\"18\" rx=\"2\"\/><path d=\"M16 2v4M8 2v4M3 10h18\"\/><\/svg>\r\n          April 13, 2026\r\n        <\/span>\r\n        <span class=\"meta-dot\"><\/span>\r\n        <span>\r\n          <svg width=\"14\" height=\"14\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 6v6l4 2\"\/><circle cx=\"12\" cy=\"12\" r=\"9\"\/><\/svg>\r\n          10 min read\r\n        <\/span>\r\n        <span class=\"meta-dot\"><\/span>\r\n        <span>\r\n          <svg width=\"14\" height=\"14\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M9 12.75L11.25 15 15 9.75M21 12a9 9 0 11-18 0 9 9 0 0118 0z\"\/><\/svg>\r\n          Independent Review\r\n        <\/span>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/header>\r\n\r\n<!-- BODY -->\r\n<main class=\"art-body\">\r\n  <div class=\"container\">\r\n    <div class=\"content-wrap\">\r\n\r\n      <!-- DISCLOSURE -->\r\n      <div class=\"disclosure\">\r\n        <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><path d=\"M12 8v4m0 4h.01\"\/><\/svg>\r\n        <span><strong>Affiliate Disclosure:<\/strong> This article contains affiliate links to Amazon. We may earn a commission from qualifying purchases at no extra cost to you. This review is fully independent \u2014 Bausch + Lomb has not paid for placement or influenced our assessment.<\/span>\r\n      <\/div>\r\n\r\n      <!-- TOP CTA \u2014 SLOT 1 -->\r\n      <div class=\"top-cta-bar\">\r\n        <div>\r\n          <strong>PreserVision AREDS2 \u2014 The Most Prescribed Eye Supplement<\/strong>\r\n          <p>Available on Amazon \u00b7 FloraGLO\u00ae Lutein \u00b7 Exact AREDS2 trial formula \u00b7 Ophthalmologist recommended<\/p>\r\n        <\/div>\r\n        <a href=\"https:\/\/amzn.to\/4elihoe\" class=\"btn-check\" target=\"_blank\" rel=\"noopener sponsored\">\r\n          Check Availability\r\n          <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"><path d=\"M13.5 4.5L21 12m0 0l-7.5 7.5M21 12H3\"\/><\/svg>\r\n        <\/a>\r\n      <\/div>\r\n\r\n      <!-- LEAD -->\r\n      <p class=\"art-lead\">\r\n        PreserVision AREDS2 has been the most recommended eye supplement in the United States for over a decade. It is the only supplement formula validated by the largest eye nutrition clinical trial ever conducted. But supplement science has advanced since AREDS2 was published in 2013 \u2014 and newer formulas now include nutrients the original trial didn't test. So: is PreserVision AREDS2 still the gold standard, or has it been surpassed?\r\n      <\/p>\r\n\r\n      <!-- TOC -->\r\n      <nav class=\"toc\" aria-label=\"Table of contents\">\r\n        <div class=\"toc-title\">\r\n          <svg width=\"17\" height=\"17\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"#C8973A\" stroke-width=\"1.5\"><path d=\"M8.25 6.75h7.5M8.25 12h7.5M8.25 17.25h7.5\"\/><\/svg>\r\n          In This Review\r\n        <\/div>\r\n        <ol class=\"toc-list\">\r\n          <li><a href=\"#verdict\">Overall Verdict & Score<\/a><\/li>\r\n          <li><a href=\"#what-is\">What Is PreserVision AREDS2?<\/a><\/li>\r\n          <li><a href=\"#ingredients\">Ingredient Analysis \u2014 Dose by Dose<\/a><\/li>\r\n          <li><a href=\"#clinical\">The Clinical Evidence Behind It<\/a><\/li>\r\n          <li><a href=\"#pros-cons\">Pros & Cons<\/a><\/li>\r\n          <li><a href=\"#who-is-it-for\">Who Should Take It \u2014 and Who Shouldn't<\/a><\/li>\r\n          <li><a href=\"#vs-competitors\">PreserVision AREDS2 vs. Newer Formulas<\/a><\/li>\r\n          <li><a href=\"#verdict-final\">Final Verdict<\/a><\/li>\r\n          <li><a href=\"#faq\">Frequently Asked Questions<\/a><\/li>\r\n        <\/ol>\r\n      <\/nav>\r\n\r\n      <!-- VERDICT CARD -->\r\n      <section id=\"verdict\">\r\n        <div class=\"verdict-card\">\r\n          <div class=\"verdict-header\">\r\n            <div>\r\n              <div class=\"verdict-title\">PreserVision AREDS2<\/div>\r\n              <div class=\"verdict-sub\">by Bausch + Lomb \u00b7 AMD Prevention \u00b7 Softgel + Mini-Tablet<\/div>\r\n            <\/div>\r\n            <div class=\"overall-score\">\r\n              <span class=\"score-num\">4.2<\/span><span class=\"score-max\">\/5<\/span>\r\n              <span class=\"score-label-text\">Overall Score<\/span>\r\n            <\/div>\r\n          <\/div>\r\n\r\n          <div class=\"product-snapshot\">\r\n            <div class=\"snapshot-item\"><span class=\"s-label\">Manufacturer<\/span><span class=\"s-value\">Bausch + Lomb (B+L)<\/span><\/div>\r\n            <div class=\"snapshot-item\"><span class=\"s-label\">Serving Size<\/span><span class=\"s-value\">2 softgels + 2 mini-tablets daily<\/span><\/div>\r\n            <div class=\"snapshot-item\"><span class=\"s-label\">Key Ingredients<\/span><span class=\"s-value\">Lutein 10 mg, Zeaxanthin 2 mg, Vit C 500 mg, Vit E 400 IU, Zinc 80 mg, Copper 2 mg<\/span><\/div>\r\n            <div class=\"snapshot-item\"><span class=\"s-label\">Availability<\/span><span class=\"s-value\">Amazon, pharmacies, ophthalmology offices<\/span><\/div>\r\n            <div class=\"snapshot-item\"><span class=\"s-label\">Lutein Source<\/span><span class=\"s-value\">FloraGLO\u00ae (Kemin Industries)<\/span><\/div>\r\n            <div class=\"snapshot-item\"><span class=\"s-label\">Guarantee<\/span><span class=\"s-value\">Standard retail return policy<\/span><\/div>\r\n          <\/div>\r\n\r\n          <div class=\"score-bars\">\r\n            <div class=\"score-bar-item\">\r\n              <div class=\"bar-label\">Ingredient Quality <span>9\/10<\/span><\/div>\r\n              <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:90%\"><\/div><\/div>\r\n            <\/div>\r\n            <div class=\"score-bar-item\">\r\n              <div class=\"bar-label\">Core Dose Accuracy <span>10\/10<\/span><\/div>\r\n              <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:100%\"><\/div><\/div>\r\n            <\/div>\r\n            <div class=\"score-bar-item\">\r\n              <div class=\"bar-label\">Clinical Evidence <span>10\/10<\/span><\/div>\r\n              <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:100%\"><\/div><\/div>\r\n            <\/div>\r\n            <div class=\"score-bar-item\">\r\n              <div class=\"bar-label\">Formula Completeness <span>6\/10<\/span><\/div>\r\n              <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:60%\"><\/div><\/div>\r\n            <\/div>\r\n            <div class=\"score-bar-item\">\r\n              <div class=\"bar-label\">Value for Money <span>8\/10<\/span><\/div>\r\n              <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:80%\"><\/div><\/div>\r\n            <\/div>\r\n            <div class=\"score-bar-item\">\r\n              <div class=\"bar-label\">Accessibility <span>10\/10<\/span><\/div>\r\n              <div class=\"bar-track\"><div class=\"bar-fill\" style=\"width:100%\"><\/div><\/div>\r\n            <\/div>\r\n          <\/div>\r\n        <\/div>\r\n      <\/section>\r\n\r\n      <!-- WHAT IS IT -->\r\n      <section id=\"what-is\">\r\n        <h2>What Is PreserVision AREDS2?<\/h2>\r\n        <p>PreserVision AREDS2 is a dietary supplement manufactured by Bausch + Lomb that replicates the exact nutrient formula tested in the <strong>Age-Related Eye Disease Study 2 (AREDS2)<\/strong> \u2014 a landmark 5-year, 4,203-participant randomised controlled trial conducted by the National Eye Institute and published in <em>JAMA<\/em> in 2013.<\/p>\r\n        <p>The AREDS2 formula replaced beta-carotene from the original AREDS formula with lutein and zeaxanthin, eliminating the lung cancer risk beta-carotene posed in smokers while achieving superior AMD risk reduction. PreserVision is currently the <strong>most prescribed eye supplement in the United States<\/strong> \u2014 recommended by more ophthalmologists than any other single product.<\/p>\r\n        <p>The formula comes in two components taken daily: two soft gels (containing the lutein, zeaxanthin and antioxidant vitamins) and two mini-tablets (containing the zinc and copper). This split-format design separates the fat-soluble carotenoids (which absorb better in a softgel with an oil carrier) from the mineral components.<\/p>\r\n      <\/section>\r\n\r\n      <!-- INGREDIENTS -->\r\n      <section id=\"ingredients\">\r\n        <h2>Ingredient Analysis \u2014 Dose by Dose<\/h2>\r\n        <p>Every ingredient in PreserVision AREDS2 matches the exact doses used in the AREDS2 trial \u2014 this is the formula's greatest strength and the primary reason ophthalmologists continue to recommend it above newer alternatives for diagnosed AMD patients.<\/p>\r\n\r\n        <table class=\"ing-table\">\r\n          <thead>\r\n            <tr><th>Ingredient<\/th><th>Dose per Day<\/th><th>Source \/ Form<\/th><th>AREDS2 Match<\/th><th>Assessment<\/th><\/tr>\r\n          <\/thead>\r\n          <tbody>\r\n            <tr><td>Lutein<\/td><td>10 mg<\/td><td>FloraGLO\u00ae (Kemin)<\/td><td class=\"dose-ok\">\u2713 Exact<\/td><td class=\"dose-ok\">\u2713 Best clinical source<\/td><\/tr>\r\n            <tr><td>Zeaxanthin<\/td><td>2 mg<\/td><td>OPTISHARP\u00ae (DSM)<\/td><td class=\"dose-ok\">\u2713 Exact<\/td><td class=\"dose-ok\">\u2713 Branded, validated<\/td><\/tr>\r\n            <tr><td>Vitamin C<\/td><td>500 mg<\/td><td>Ascorbic acid<\/td><td class=\"dose-ok\">\u2713 Exact<\/td><td class=\"dose-ok\">\u2713 Standard form<\/td><\/tr>\r\n            <tr><td>Vitamin E<\/td><td>400 IU<\/td><td>dl-alpha-tocopheryl acetate<\/td><td class=\"dose-ok\">\u2713 Exact<\/td><td class=\"dose-mid\">~ Synthetic form (d-alpha preferred)<\/td><\/tr>\r\n            <tr><td>Zinc<\/td><td>80 mg<\/td><td>Zinc oxide<\/td><td class=\"dose-ok\">\u2713 Exact<\/td><td class=\"dose-mid\">~ High dose; less bioavailable form<\/td><\/tr>\r\n            <tr><td>Copper<\/td><td>2 mg<\/td><td>Cupric oxide<\/td><td class=\"dose-ok\">\u2713 Exact<\/td><td class=\"dose-ok\">\u2713 Balances zinc depletion<\/td><\/tr>\r\n          <\/tbody>\r\n        <\/table>\r\n\r\n        <h3>Two Notable Ingredient Observations<\/h3>\r\n\r\n        <h4>Vitamin E: Synthetic Form<\/h4>\r\n        <p>PreserVision uses <strong>dl-alpha-tocopheryl acetate<\/strong> \u2014 the synthetic racemic form of vitamin E. The natural form (d-alpha-tocopherol) has approximately 2\u00d7 greater bioavailability and tissue retention. The AREDS2 trial did not distinguish between forms in its dosing \u2014 this is a genuine quality gap that premium competitors have addressed by switching to natural d-alpha-tocopherol.<\/p>\r\n\r\n        <h4>Zinc: High Dose, Lower Bioavailability Form<\/h4>\r\n        <p>The 80 mg zinc dose as zinc oxide matches the AREDS2 trial exactly. However, zinc oxide has lower bioavailability than zinc citrate or zinc glycinate. More importantly, 80 mg\/day is a therapeutically high dose \u2014 meaningful for patients with diagnosed intermediate AMD but potentially more than necessary for healthy adults. PreserVision does offer a lower-zinc variant (25 mg) for this reason.<\/p>\r\n\r\n        <div class=\"callout callout-warn\">\r\n          <div class=\"callout-icon\">\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126z\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"callout-body\">\r\n            <strong>Important: Always Take with Food<\/strong>\r\n            <p>The 80 mg zinc and 500 mg vitamin C doses can cause nausea and stomach upset on an empty stomach. Always take PreserVision AREDS2 with a meal \u2014 ideally one containing fat, which will also improve lutein and zeaxanthin absorption. The 2 mg copper is included to prevent zinc-induced copper depletion; do not take additional copper above this unless medically supervised.<\/p>\r\n          <\/div>\r\n        <\/div>\r\n      <\/section>\r\n\r\n      <!-- CLINICAL EVIDENCE -->\r\n      <section id=\"clinical\">\r\n        <h2>The Clinical Evidence Behind It<\/h2>\r\n        <p>No eye supplement in history has a more rigorous evidence base than PreserVision AREDS2. The key data points:<\/p>\r\n\r\n        <h3>The AREDS2 Trial (2006\u20132012, published 2013)<\/h3>\r\n        <p><strong>Design:<\/strong> Randomised, double-blind, placebo-controlled. 4,203 participants aged 50\u201385 with intermediate AMD or advanced AMD in one eye. Followed for a median of 5 years. <strong>Primary outcome:<\/strong> progression to advanced AMD.<\/p>\r\n        <p><strong>Key finding:<\/strong> Participants assigned to the lutein\/zeaxanthin formula had a <strong>26% lower risk<\/strong> of progression to advanced AMD compared to those taking no lutein\/zeaxanthin. The benefit was greatest in participants with low dietary lutein\/zeaxanthin intake at baseline \u2014 confirming the supplementation mechanism.<\/p>\r\n        <p><strong>Beta-carotene comparison:<\/strong> Lutein\/zeaxanthin outperformed beta-carotene for AMD risk reduction and was safe in smokers (beta-carotene was not). This finding directly led to the reformulation of the original AREDS formula.<\/p>\r\n\r\n        <h3>10-Year Follow-Up (AREDS2 Extension, published 2022)<\/h3>\r\n        <p>The long-term extension study, published in <em>JAMA Ophthalmology<\/em>, confirmed that benefits persisted with sustained use over 10 years. Participants who continued supplementation maintained significantly lower rates of AMD progression compared to those who discontinued. <strong>This is the longest-duration evidence base for any eye supplement formula.<\/strong><\/p>\r\n\r\n        <div class=\"callout callout-gold\">\r\n          <div class=\"callout-icon\">\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M9 12.75L11.25 15 15 9.75M21 12a9 9 0 11-18 0 9 9 0 0118 0z\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"callout-body\">\r\n            <strong>Why the Evidence Base Matters<\/strong>\r\n            <p>Most eye supplements \u2014 including many premium formulas \u2014 rely on individual ingredient trials rather than product-specific clinical validation. PreserVision AREDS2 is the exact formula tested in the trial that generated the data ophthalmologists cite. When an eye doctor recommends \"AREDS2 supplementation,\" they are specifically recommending this formula or a bioequivalent. No amount of premium ingredients changes the fact that PreserVision's clinical validation is unmatched.<\/p>\r\n          <\/div>\r\n        <\/div>\r\n      <\/section>\r\n\r\n      <!-- PROS CONS -->\r\n      <section id=\"pros-cons\">\r\n        <h2>Pros &amp; Cons<\/h2>\r\n        <div class=\"pros-cons\">\r\n          <div class=\"pros\">\r\n            <h4>What PreserVision AREDS2 Does Well<\/h4>\r\n            <ul>\r\n              <li>Exact AREDS2 formula \u2014 fully validated<\/li>\r\n              <li>FloraGLO\u00ae lutein and OPTISHARP\u00ae zeaxanthin at clinical doses<\/li>\r\n              <li>Most recommended by ophthalmologists<\/li>\r\n              <li>10-year long-term safety and efficacy data<\/li>\r\n              <li>Available in pharmacies \u2014 no online order required<\/li>\r\n              <li>Multiple variants: standard, mini-gels, lower zinc, + omega-3<\/li>\r\n              <li>Competitive price for an AREDS2-validated product<\/li>\r\n              <li>NSF certified \u2014 third-party verified for label accuracy<\/li>\r\n            <\/ul>\r\n          <\/div>\r\n          <div class=\"cons\">\r\n            <h4>Where It Falls Short in 2026<\/h4>\r\n            <ul>\r\n              <li>No astaxanthin \u2014 misses screen fatigue protection entirely<\/li>\r\n              <li>No meso-zeaxanthin \u2014 no triple carotenoid benefit<\/li>\r\n              <li>No omega-3s (unless omega-3 variant chosen)<\/li>\r\n              <li>Synthetic vitamin E form (dl-alpha vs. natural d-alpha)<\/li>\r\n              <li>Zinc oxide \u2014 lower bioavailability than zinc citrate<\/li>\r\n              <li>4 pills per day (2 softgels + 2 mini-tablets)<\/li>\r\n              <li>No bilberry, saffron or additional phytonutrients<\/li>\r\n              <li>80 mg zinc may be excessive for healthy adults without AMD<\/li>\r\n            <\/ul>\r\n          <\/div>\r\n        <\/div>\r\n      <\/section>\r\n\r\n      <!-- WHO IS IT FOR -->\r\n      <section id=\"who-is-it-for\">\r\n        <h2>Who Should Take It \u2014 and Who Shouldn't<\/h2>\r\n\r\n        <div class=\"who-grid\">\r\n          <div class=\"who-card\">\r\n            <span class=\"w-icon who-yes\">\u2713 Well-suited for<\/span>\r\n            <h4>AMD-Diagnosed Patients<\/h4>\r\n            <p>If an ophthalmologist has diagnosed intermediate AMD, this is the most evidence-backed formula available and the one most doctors will specifically recommend. The clinical data applies directly to your situation.<\/p>\r\n          <\/div>\r\n          <div class=\"who-card\">\r\n            <span class=\"w-icon who-yes\">\u2713 Well-suited for<\/span>\r\n            <h4>Strong Family History of AMD<\/h4>\r\n            <p>First-degree relatives of AMD patients have 2\u20134\u00d7 the average risk. PreserVision provides the most validated foundational protection for high-risk individuals who want an ophthalmologist-endorsed formula.<\/p>\r\n          <\/div>\r\n          <div class=\"who-card\">\r\n            <span class=\"w-icon who-yes\">\u2713 Well-suited for<\/span>\r\n            <h4>Adults Over 55 Seeking Prevention<\/h4>\r\n            <p>For adults in their late 50s and beyond seeking general AMD prevention, PreserVision AREDS2 is a dependable, accessible choice \u2014 particularly if a healthcare provider has recommended the AREDS2 approach.<\/p>\r\n          <\/div>\r\n          <div class=\"who-card\">\r\n            <span class=\"w-icon who-no\">\u2212 Less ideal for<\/span>\r\n            <h4>Screen Workers Under 50<\/h4>\r\n            <p>For the 30\u201350 demographic spending 6+ hours daily on screens, PreserVision lacks astaxanthin (the key nutrient for screen fatigue), meso-zeaxanthin and omega-3s at optimal doses. A premium complete formula is a better fit for this profile.<\/p>\r\n          <\/div>\r\n          <div class=\"who-card\">\r\n            <span class=\"w-icon who-no\">\u2212 Less ideal for<\/span>\r\n            <h4>Smokers (Any Age)<\/h4>\r\n            <p>AREDS2 is safe for smokers \u2014 it replaced beta-carotene specifically to address this concern. However, smokers benefit more from the antioxidant-heavy premium formulas with higher vitamin C and astaxanthin, given the severe oxidative burden smoking adds to ocular tissue.<\/p>\r\n          <\/div>\r\n          <div class=\"who-card\">\r\n            <span class=\"w-icon who-no\">\u2212 Less ideal for<\/span>\r\n            <h4>Those Wanting a Single Daily Pill<\/h4>\r\n            <p>The 4-component daily serving (2 softgels + 2 mini-tablets) is inconvenient compared to single-softgel alternatives. Adherence decreases with more complex dosing regimens \u2014 a real-world consideration for long-term use.<\/p>\r\n          <\/div>\r\n        <\/div>\r\n      <\/section>\r\n\r\n      <!-- MID CTA \u2014 SLOT 2 -->\r\n      <div class=\"mid-cta\">\r\n        <div class=\"mid-cta-text\">\r\n          <strong>PreserVision AREDS2 \u2014 Check Current Price<\/strong>\r\n          <p>Available on Amazon with free shipping. Multiple pack sizes available \u2014 60, 120 and 210 softgel counts.<\/p>\r\n        <\/div>\r\n        <a href=\"https:\/\/amzn.to\/4elihoe\" class=\"btn-mid\" target=\"_blank\" rel=\"noopener sponsored\">\r\n          Check Availability \u2192\r\n        <\/a>\r\n      <\/div>\r\n\r\n      <!-- VS COMPETITORS -->\r\n      <div class=\"sec-divider\"><span>How It Compares<\/span><\/div>\r\n      <section id=\"vs-competitors\">\r\n        <h2>PreserVision AREDS2 vs. Newer Formulas<\/h2>\r\n        <p>The honest assessment: PreserVision AREDS2 is unmatched for its specific intended use \u2014 slowing AMD progression in diagnosed patients. But for the broader population seeking comprehensive eye protection in 2026, newer formulas have meaningfully expanded on the AREDS2 foundation.<\/p>\r\n\r\n        <div class=\"vs-table-wrap\">\r\n          <table class=\"vs-table\">\r\n            <thead>\r\n              <tr>\r\n                <th>Formula<\/th>\r\n                <th>AREDS2 Base<\/th>\r\n                <th>Astaxanthin<\/th>\r\n                <th>Meso-ZX<\/th>\r\n                <th>Omega-3<\/th>\r\n                <th>Best For<\/th>\r\n              <\/tr>\r\n            <\/thead>\r\n            <tbody>\r\n              <tr>\r\n                <td class=\"highlight\">PreserVision AREDS2<\/td>\r\n                <td><span class=\"check\">\u2713 Exact trial formula<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 None<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 None<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 Separate variant<\/span><\/td>\r\n                <td>AMD patients, highest clinical validation<\/td>\r\n              <\/tr>\r\n              <tr>\r\n                <td>Eagle Eye X20<\/td>\r\n                <td><span class=\"check\">\u2713 Full AREDS2 base<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 12 mg AstaReal\u00ae<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 10 mg included<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 800 mg TG form<\/span><\/td>\r\n                <td>Screen workers, comprehensive prevention<\/td>\r\n              <\/tr>\r\n              <tr>\r\n                <td>iGenics<\/td>\r\n                <td><span class=\"partial\">~ Lutein\/ZX only<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 6 mg AstaReal\u00ae<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 10 mg included<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 None<\/span><\/td>\r\n                <td>Premium triple carotenoid + fatigue<\/td>\r\n              <\/tr>\r\n              <tr>\r\n                <td>MacuHealth<\/td>\r\n                <td><span class=\"cross\">\u2717 No<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 None<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 10 mg included<\/span><\/td>\r\n                <td><span class=\"check\">\u2713 DHA included<\/span><\/td>\r\n                <td>Maximum MPOD \u2014 clinician-directed<\/td>\r\n              <\/tr>\r\n              <tr>\r\n                <td>Ocuvite Complete 50+<\/td>\r\n                <td><span class=\"check\">\u2713 Full AREDS2<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 None<\/span><\/td>\r\n                <td><span class=\"cross\">\u2717 None<\/span><\/td>\r\n                <td><span class=\"partial\">~ Low dose<\/span><\/td>\r\n                <td>Budget pharmacy alternative<\/td>\r\n              <\/tr>\r\n            <\/tbody>\r\n          <\/table>\r\n        <\/div>\r\n\r\n        <h3>The Verdict on \"Gold Standard\" Status<\/h3>\r\n        <p>PreserVision AREDS2 remains the <strong>gold standard specifically for AMD progression management<\/strong> \u2014 no formula has more clinical validation for this indication, and none likely will without a multi-year multi-thousand-participant RCT to match AREDS2. In this context, its status is secure.<\/p>\r\n        <p>For <strong>general eye health prevention<\/strong> \u2014 particularly for screen workers under 55 without diagnosed AMD \u2014 it is no longer the most comprehensive option. Eagle Eye X20, iGenics and MacuHealth each offer meaningful additional protection through astaxanthin, meso-zeaxanthin or both. The gap is not in what PreserVision includes, but in what post-AREDS2 science has since added to the picture.<\/p>\r\n        <p>The practical recommendation: <strong>if an ophthalmologist has recommended AREDS2 supplementation, use PreserVision<\/strong>. For everyone else, a premium formula that builds on the AREDS2 foundation with additional carotenoids and astaxanthin provides broader protection.<\/p>\r\n      <\/section>\r\n\r\n      <!-- FINAL VERDICT -->\r\n      <div class=\"sec-divider\"><span>Final Verdict<\/span><\/div>\r\n      <section id=\"verdict-final\">\r\n        <h2>Final Verdict<\/h2>\r\n        <p>PreserVision AREDS2 earns a <strong>4.2\/5<\/strong> \u2014 a strong score driven by the most validated evidence base in the category and the use of FloraGLO\u00ae and OPTISHARP\u00ae branded carotenoids at exact clinical doses. It loses points for the absence of astaxanthin, meso-zeaxanthin and omega-3s in the base formula, the synthetic vitamin E form, and a serving size that requires four pills per day.<\/p>\r\n        <p>For AMD patients following ophthalmologist guidance: <strong>take PreserVision AREDS2<\/strong>. Consider adding the omega-3 variant or a separate quality fish oil, and optionally adding standalone astaxanthin for screen fatigue coverage.<\/p>\r\n        <p>For healthy adults under 55 seeking general prevention: PreserVision provides a solid foundation, but a comprehensive formula like Eagle Eye X20 that builds on the AREDS2 base with additional protective layers is a more complete daily solution for the modern, screen-heavy lifestyle.<\/p>\r\n      <\/section>\r\n\r\n      <!-- FINAL CTA \u2014 SLOT 3 -->\r\n      <div class=\"final-cta\">\r\n        <h2>Check Current Price &amp; Availability<\/h2>\r\n        <p>Available on Amazon in multiple pack sizes. Or compare the most complete formulas that build on the AREDS2 foundation.<\/p>\r\n        <div class=\"cta-btn-row\">\r\n          <a href=\"https:\/\/amzn.to\/4elihoe\" class=\"btn-gold\" target=\"_blank\" rel=\"noopener sponsored\">\r\n            Check Availability \u2014 PreserVision\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" width=\"14\" height=\"14\"><path d=\"M13.5 4.5L21 12m0 0l-7.5 7.5M21 12H3\"\/><\/svg>\r\n          <\/a>\r\n          <a href=\"\/best-eye-vitamins-complete-formula\/\" class=\"btn-ghost-light\">\r\n            Compare Complete Formulas \u2192\r\n          <\/a>\r\n        <\/div>\r\n      <\/div>\r\n\r\n      <!-- FAQ -->\r\n      <section id=\"faq\">\r\n        <h2>Frequently Asked Questions<\/h2>\r\n\r\n        <div class=\"faq-item\">\r\n          <div class=\"faq-q\" onclick=\"toggleFAQ(this)\">\r\n            Is PreserVision AREDS2 worth taking?\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 4.5v15m7.5-7.5h-15\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"faq-a\">Yes \u2014 for its intended population. For people with intermediate AMD or advanced AMD in one eye, it is the most clinically validated formula available and the one their ophthalmologist is most likely to recommend. For general prevention in healthy adults without diagnosed AMD, it is a solid foundation but lacks astaxanthin, meso-zeaxanthin and optimal omega-3 doses that premium comprehensive formulas now include.<\/div>\r\n        <\/div>\r\n\r\n        <div class=\"faq-item\">\r\n          <div class=\"faq-q\" onclick=\"toggleFAQ(this)\">\r\n            What are the side effects of PreserVision AREDS2?\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 4.5v15m7.5-7.5h-15\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"faq-a\">The most common concern is the 80 mg zinc dose, which can cause nausea when taken on an empty stomach. The 2 mg copper in the formula addresses the copper depletion risk from high-dose zinc. Vitamin C at 500 mg may cause mild stomach upset in sensitive individuals. Always take with a fat-containing meal. Serious adverse effects are rare at these doses in the AREDS2 trial population.<\/div>\r\n        <\/div>\r\n\r\n        <div class=\"faq-item\">\r\n          <div class=\"faq-q\" onclick=\"toggleFAQ(this)\">\r\n            How long does PreserVision AREDS2 take to work?\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 4.5v15m7.5-7.5h-15\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"faq-a\">In the AREDS2 trial, the primary outcome was AMD progression over a 5-year period \u2014 not subjective symptom improvement. Measurable increases in macular pigment optical density from lutein and zeaxanthin begin appearing after 3\u20136 months of consistent use. Subjective visual improvements are uncommon from this formula alone \u2014 it is designed to slow structural deterioration, not reverse it. Consistent daily use for years is what generates the cumulative protective benefit.<\/div>\r\n        <\/div>\r\n\r\n        <div class=\"faq-item\">\r\n          <div class=\"faq-q\" onclick=\"toggleFAQ(this)\">\r\n            Can I take PreserVision AREDS2 if I don't have AMD?\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 4.5v15m7.5-7.5h-15\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"faq-a\">Yes. The core nutrients support macular health at any stage. The 80 mg zinc dose is designed for high-risk AMD patients and may exceed what is necessary for healthy adults without AMD \u2014 the lower-zinc PreserVision variant (25 mg zinc) may be more appropriate. For comprehensive general prevention, a formula that also includes astaxanthin and meso-zeaxanthin provides broader coverage than the AREDS2 base alone.<\/div>\r\n        <\/div>\r\n\r\n        <div class=\"faq-item\">\r\n          <div class=\"faq-q\" onclick=\"toggleFAQ(this)\">\r\n            What is the difference between PreserVision AREDS2 and PreserVision AREDS2 + Omega-3?\r\n            <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\"><path d=\"M12 4.5v15m7.5-7.5h-15\"\/><\/svg>\r\n          <\/div>\r\n          <div class=\"faq-a\">The omega-3 variant adds DHA-rich fish oil to the base formula, addressing dry eye, retinal structural integrity and anti-inflammatory pathways that the base formula doesn't cover. If you don't already take a separate fish oil supplement, the omega-3 variant is a better choice. If you already take 1,000\u20132,000 mg EPA+DHA daily from a separate fish oil, the standard formula is sufficient and the omega-3 inclusion would be redundant.<\/div>\r\n        <\/div>\r\n      <\/section>\r\n\r\n      <!-- SHARE -->\r\n      <div class=\"share-bar\">\r\n        <span class=\"share-label\">Share this review<\/span>\r\n        <button class=\"share-btn\" onclick=\"navigator.clipboard.writeText(window.location.href)\">\r\n          <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.5\" width=\"14\" height=\"14\"><path d=\"M13.19 8.688a4.5 4.5 0 011.242 7.244l-4.5 4.5a4.5 4.5 0 01-6.364-6.364l1.757-1.757m13.35-.622l1.757-1.757a4.5 4.5 0 00-6.364-6.364l-4.5 4.5a4.5 4.5 0 001.242 7.244\"\/><\/svg>\r\n          Copy Link\r\n        <\/button>\r\n        <a class=\"share-btn\" href=\"https:\/\/twitter.com\/intent\/tweet?text=PreserVision+AREDS2+Review+2026&amp;url=https:\/\/nutra-supplements.com\/preservision-areds2-review\/\" target=\"_blank\" rel=\"noopener\">\r\n          <svg viewBox=\"0 0 24 24\" fill=\"currentColor\" width=\"13\" height=\"13\"><path d=\"M18.244 2.25h3.308l-7.227 8.26 8.502 11.24H16.17l-4.714-6.231-5.401 6.231H2.746l7.73-8.835L1.254 2.25H8.08l4.713 6.231zm-1.161 17.52h1.833L7.084 4.126H5.117z\"\/><\/svg>\r\n          X \/ Twitter\r\n        <\/a>\r\n        <a class=\"share-btn\" href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/nutra-supplements.com\/preservision-areds2-review\/\" target=\"_blank\" rel=\"noopener\">\r\n          <svg viewBox=\"0 0 24 24\" fill=\"currentColor\" width=\"13\" height=\"13\"><path d=\"M24 12.073c0-6.627-5.373-12-12-12s-12 5.373-12 12c0 5.99 4.388 10.954 10.125 11.854v-8.385H7.078v-3.47h3.047V9.43c0-3.007 1.792-4.669 4.533-4.669 1.312 0 2.686.235 2.686.235v2.953H15.83c-1.491 0-1.956.925-1.956 1.874v2.25h3.328l-.532 3.47h-2.796v8.385C19.612 23.027 24 18.062 24 12.073z\"\/><\/svg>\r\n          Facebook\r\n        <\/a>\r\n      <\/div>\r\n\r\n      <!-- RELATED -->\r\n      <section>\r\n        <h2 style=\"margin-bottom:0.5rem;\">Continue in the Vision Health Hub<\/h2>\r\n        <p style=\"color:var(--ink-light); font-size:0.9rem; margin-bottom:1.4rem;\">Related articles in the series:<\/p>\r\n        <div class=\"related-grid\">\r\n          <a href=\"\/macuhealth-vs-eyepromise\/\" class=\"related-card\">\r\n            <span class=\"related-type\">Comparison<\/span>\r\n            <div class=\"related-title\">MacuHealth vs. EyePromise Restore \u2014 Which Wins?<\/div>\r\n          <\/a>\r\n          <a href=\"\/best-eye-vitamins-complete-formula\/\" class=\"related-card\">\r\n            <span class=\"related-type\">Product Review<\/span>\r\n            <div class=\"related-title\">Best Complete Eye Vitamin Formulas 2026 \u2014 All-in-One Ranked<\/div>\r\n          <\/a>\r\n          <a href=\"\/macular-degeneration-prevention-supplements\/\" class=\"related-card\">\r\n            <span class=\"related-type\">Science Guide<\/span>\r\n            <div class=\"related-title\">Macular Degeneration Prevention: What the Science Says<\/div>\r\n          <\/a>\r\n          <a href=\"\/category\/vision-health\/\" class=\"related-card\">\r\n            <span class=\"related-type\">Hub Index<\/span>\r\n            <div class=\"related-title\">\u2190 Back to Vision Health Hub \u2014 All 12 Articles<\/div>\r\n          <\/a>\r\n        <\/div>\r\n      <\/section>\r\n\r\n    <\/div>\r\n  <\/div>\r\n<\/main>\r\n\r\n<!-- FOOTER -->\r\n<footer>\r\n  <div class=\"container\">\r\n    <p class=\"footer-disclaimer\">\r\n      This website participates in affiliate programs including the Amazon Services LLC Associates Program and other international affiliate networks. We may earn commissions from qualifying purchases at no extra cost to you. All reviews are independent and based solely on ingredient quality and clinical evidence. Content is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any supplement regimen.\r\n    <\/p>\r\n    <nav class=\"footer-links\">\r\n      <a href=\"\/affiliate-disclosure\/\">Affiliate Disclosure<\/a>\r\n      <a href=\"\/privacy-policy\/\">Privacy Policy<\/a>\r\n      <a href=\"\/contact\/\">Contact<\/a>\r\n    <\/nav>\r\n    <p class=\"footer-copy\">\u00a9 2026 Nutra-Supplements.com \u2013 All Rights Reserved.<\/p>\r\n  <\/div>\r\n<\/footer>\r\n\r\n<script>\r\nfunction toggleFAQ(el) {\r\n  el.classList.toggle('open');\r\n  el.nextElementSibling.classList.toggle('visible');\r\n}\r\nwindow.addEventListener('scroll', () => {\r\n  const d = document.documentElement;\r\n  document.getElementById('progress').style.width = (d.scrollTop \/ (d.scrollHeight - d.clientHeight) * 100) + '%';\r\n});\r\n<\/script>\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard? | Nutra Supplements Vision Health Complete Formulas Home EN ES DE FR IT Home Vision Health Complete Eye Formulas PreserVision AREDS2 Review Product Review \u00b7 Vision Health PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard? April 13, 2026 10 min read &#8230; <a title=\"PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard? | Nutra Supplements\" class=\"read-more\" href=\"https:\/\/nutra-supplements.com\/fr\/preservision-areds2-review\/\" aria-label=\"Read more about PreserVision AREDS2 Review (2026) \u2014 Is It Still the Gold Standard? | Nutra Supplements\">Lire la suite<\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"class_list":["post-399","post","type-post","status-publish","format-standard","hentry","category-vision-health"],"_links":{"self":[{"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/posts\/399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/comments?post=399"}],"version-history":[{"count":7,"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/posts\/399\/revisions"}],"predecessor-version":[{"id":407,"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/posts\/399\/revisions\/407"}],"wp:attachment":[{"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/media?parent=399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/categories?post=399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nutra-supplements.com\/fr\/wp-json\/wp\/v2\/tags?post=399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}